Drug Type Small molecule drug |
Synonyms Helidac |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), DNA synthesis inhibitors, Protein biosynthesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (15 Aug 1996), |
Regulation- |
Molecular FormulaC6H9N3O3 |
InChIKeyVAOCPAMSLUNLGC-UHFFFAOYSA-N |
CAS Registry443-48-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Duodenal Ulcer | United States | 15 Aug 1996 | |
| Helicobacter pylori infection | United States | 15 Aug 1996 |





